explore -WSS

explore

author：hotspot 2025-10-06 14:37:31 Page View：76

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： In shift, Texas to cover initial consult for Afghan baby's gene therapy
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

explore

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Medical devices makers are asking for forgiveness, not permission

AdobeInarecentsurveyofU.S.companies,medicaldevicemakersreportedspending$31milliononaveragetobringane

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Study suggests new cause of Down syndrome: cells linked to aging

NeuralprogenitorcellsderivedfromstemcellsofapersonwithDownsyndrome.CourtesyHiruyMeharenaDownsyndrome